Welcome to LookChem.com Sign In|Join Free

CAS

  • or
4-Pyridinepropenoic acid methyl ester, also known as methyl 4-pyridylacrylate, is a chemical compound characterized by its molecular formula C8H7NO2. It presents as a colorless to pale yellow liquid with a strong odor, and is recognized for its role in the synthesis of various products, including pharmaceuticals, agrochemicals, and flavor and fragrance compounds. Additionally, it serves as an intermediate in the manufacturing of other organic compounds. Due to its potential environmental and health hazards, it is crucial to handle this chemical with care and in accordance with safety guidelines.

7340-34-3 Suppliers

Post Buying Request

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • 7340-34-3 Structure
  • Basic information

    1. Product Name: 4-Pyridinepropenoic acid methyl ester
    2. Synonyms: 4-Pyridinepropenoic acid methyl ester;4-Pyridineacrylic acid, methyl ester;Acrylic acid, 3-(4-pyridyl)-, methyl ester;Methyl-beta-(4-pyridyl)-acrylate;Nsc 84239;2-Propenoic acid, 3-(4-pyridinyl)-, Methyl ester;Methyl 3-(pyridin-4-yl)acrylate;3-(4-pyridinyl)-2-Propenoic acid methyl ester
    3. CAS NO:7340-34-3
    4. Molecular Formula: C9H9NO2
    5. Molecular Weight: 163.17
    6. EINECS: N/A
    7. Product Categories: N/A
    8. Mol File: 7340-34-3.mol
  • Chemical Properties

    1. Melting Point: N/A
    2. Boiling Point: 277.8°C at 760 mmHg
    3. Flash Point: 121.8°C
    4. Appearance: /
    5. Density: 1.136g/cm3
    6. Vapor Pressure: 0.00443mmHg at 25°C
    7. Refractive Index: 1.562
    8. Storage Temp.: under inert gas (nitrogen or Argon) at 2-8°C
    9. Solubility: N/A
    10. CAS DataBase Reference: 4-Pyridinepropenoic acid methyl ester(CAS DataBase Reference)
    11. NIST Chemistry Reference: 4-Pyridinepropenoic acid methyl ester(7340-34-3)
    12. EPA Substance Registry System: 4-Pyridinepropenoic acid methyl ester(7340-34-3)
  • Safety Data

    1. Hazard Codes: N/A
    2. Statements: N/A
    3. Safety Statements: N/A
    4. WGK Germany:
    5. RTECS:
    6. HazardClass: N/A
    7. PackingGroup: N/A
    8. Hazardous Substances Data: 7340-34-3(Hazardous Substances Data)

7340-34-3 Usage

Uses

Used in Pharmaceutical Synthesis:
4-Pyridinepropenoic acid methyl ester is used as a key intermediate in the synthesis of pharmaceuticals for its ability to contribute to the development of new drugs with potential therapeutic applications.
Used in Agrochemical Production:
In the agrochemical industry, 4-Pyridinepropenoic acid methyl ester is utilized as a component in the production of various agrochemicals, contributing to the creation of products that enhance crop protection and yield.
Used in Flavor and Fragrance Industry:
4-Pyridinepropenoic acid methyl ester is employed as a building block in the formulation of flavor and fragrance compounds, leveraging its chemical properties to create unique scents and tastes for various consumer products.
Used in Organic Compound Manufacturing:
As an intermediate, 4-Pyridinepropenoic acid methyl ester is instrumental in the manufacturing of other organic compounds, playing a pivotal role in the synthesis of a wide range of chemical products.

Check Digit Verification of cas no

The CAS Registry Mumber 7340-34-3 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 7,3,4 and 0 respectively; the second part has 2 digits, 3 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 7340-34:
(6*7)+(5*3)+(4*4)+(3*0)+(2*3)+(1*4)=83
83 % 10 = 3
So 7340-34-3 is a valid CAS Registry Number.
InChI:InChI=1/C9H9NO2/c1-12-9(11)3-2-8-4-6-10-7-5-8/h2-7H,1H3/b3-2+

7340-34-3SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 11, 2017

Revision Date: Aug 11, 2017

1.Identification

1.1 GHS Product identifier

Product name Methyl-β-(4-pyridyl)-acrylate

1.2 Other means of identification

Product number -
Other names 4-Pyridineacrylic acid,methyl ester

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:7340-34-3 SDS

7340-34-3Relevant articles and documents

Uranyl-Organic Coordination Compounds Incorporating Photoactive Vinylpyridine Moieties: Synthesis, Structural Characterization, and Light-Induced Fluorescence Attenuation

Wu, Si,Mei, Lei,Li, Fei-Ze,An, Shu-Wen,Hu, Kong-Qiu,Nie, Chang-Ming,Chai, Zhi-Fang,Shi, Wei-Qun

, p. 14772 - 14785 (2018)

The fluorescence of uranyl originated from electronic transitions (S11-S00 and S10-S0v, v = 0-4) of the ligand-to-metal charge transfer (LMCT) process is an intrinsic property of many uranyl coordination compounds. However, light-induced regulation on fluorescence features of uranyl hybrid materials through photoactive functional groups is less investigated. In this work, the photoactive vinyl group-containing ligands, (E)-methyl 3-(pyridin-4-yl)acrylate and (E)-methyl 3-(pyridin-3-yl)acrylate, have been used in the construction of uranyl coordination polymers in the presence of 1,10-phenanthroline (phen). Five compounds (UO2)3(μ3-O)(μ2-OH)2(L1)2(phen)2(1), (UO2)3(μ3-O)(μ2-OH)3(L1)(phen)2 (2), (UO2)3(μ3-O)(μ2-OH)3(L2)(phen)2 (3), [(UO2)2(μ2-OH)2(L2)2(phen)2]·2H2O (4), and (UO2)Zn(SO4)(phen)(H2O)(OH)2(5) were obtained under hydrothermal conditions. Compounds 1-4 are polynuclear uranyl structures with abundant π-π interactions and hydrogen bonds contributed to the 3D crystal packing of them. As model compounds, 1 and 3 are selected for exploring photoresponsive behaviors. The emission intensities of these two compounds are found to decrease gradually over the exposure time of UV irradiation. X-ray single crystal structural analysis suggests that the fluorescence attenuation can be explained by the slight rotation of pyridinyl groups around the carbon-carbon double bond during UV irradiation, which is accompanied by the change of weak interactions, i.e., π-π interactions and hydrogen bonds in strength and density. This feature of light-induced fluorescence attenuation may enable these two compounds to act as potential photoresponsive sensor materials.

(E)-3-heteroaromatic propyl-2-enoic acid derivative as well as preparation and application thereof

-

Paragraph 0054-0056, (2020/09/10)

The invention relates to a (E)-3-heteroaromatic propyl-2-enoic acid derivative, and also relates to a preparation method and pharmaceutical application thereof. The compound is a novel Nrf2 activatorand has the effects of resisting oxidative stress, resisting neuritis and enhancing mitochondrial functions and biogenesis by effectively activating an Nrf2 signal path, so that nerve cells are protected, and the compound can be used for treating neurodegenerative diseases and cerebral apoplexy. In addition, the novel Nrf2 activator can also be used to treat autoimmune diseases, diabetes and nephropathy, and other chronic diseases.

Synthesis of olefins via a Wittig reaction mediated by triphenylarsine

Li, Lun,Stimac, Jared C.,Geary, Laina M.

supporting information, p. 1379 - 1381 (2017/03/17)

An arsine-mediated Wittig reaction for the synthesis of olefins is described. After heating triphenylarsine in the presence of an activated alkyl bromide for 30?min, the resulting arsonium salt condensed with aldehydes in as little as 5?min at room temperature, yielding the olefins in high yields. Aromatic, heteroaromatic, and alkyl aldehydes were all suitable substrates for this process.

Metal nanoparticle catalyzed cyclobutane cleavage reaction

Chen, Dengtai,Han, Xijiang,Jin, Wen,Zhang, Bin

, p. 100722 - 100724 (2015/12/05)

The pyridine substituted cyclobutane cleavage reaction can be catalyzed directly by the high surface energy of metallic silver/gold nanoparticles.

NRF2 REGULATORS

-

Page/Page column 158; 159, (2015/07/07)

The present invention relates to bis aryl analogs, pharmaceutical compositions containing them and their use as Nrf2 regulators.

Structure-guided, single-point modifications in the phosphinic dipeptide structure yield highly potent and selective inhibitors of neutral aminopeptidases

Vassiliou, Stamatia,W?glarz-Tomczak, Ewelina,Berlicki,Pawe?czak, Ma?gorzata,Nocek, Bogus?aw,Mulligan, Rory,Joachimiak, Andrzej,Mucha, Artur

, p. 8140 - 8151 (2014/12/10)

Seven crystal structures of alanyl aminopeptidase from Neisseria meningitides (the etiological agent of meningitis, NmAPN) complexed with organophosphorus compounds were resolved to determine the optimal inhibitor-enzyme interactions. The enantiomeric phosphonic acid analogs of Leu and hPhe, which correspond to the P1 amino acid residues of well-processed substrates, were used to assess the impact of the absolute configuration and the stereospecific hydrogen bond network formed between the aminophosphonate polar head and the active site residues on the binding affinity. For the hPhe analog, an imperfect stereochemical complementarity could be overcome by incorporating an appropriate P1 side chain. The constitution of P1′-extended structures was rationally designed and the lead, phosphinic dipeptide hPhePψ[CH2]Phe, was modified in a single position. Introducing a heteroatom/heteroatom-based fragment to either the P1 or P1′ residue required new synthetic pathways. The compounds in the refined structure were low nanomolar and subnanomolar inhibitors of N. meningitides, porcine and human APNs, and the reference leucine aminopeptidase (LAP). The unnatural phosphinic dipeptide analogs exhibited a high affinity for monozinc APNs associated with a reasonable selectivity versus dizinc LAP. Another set of crystal structures containing the NmAPN dipeptide ligand were used to verify and to confirm the predicted binding modes; furthermore, novel contacts, which were promising for inhibitor development, were identified, including a π-π stacking interaction between a pyridine ring and Tyr372.

A supramolecular protecting group strategy introduced to the organic solid state: Enhanced reactivity through molecular pedal motion

Elacqua, Elizabeth,Kaushik, Poonam,Groeneman, Ryan H.,Sumrak, Joseph C.,Bucar, Dejan-Kresimir,MacGillivray, Leonard R.

supporting information; experimental part, p. 1037 - 1041 (2012/02/16)

A supramolecular protecting group strategy has been applied to achieve solid-state photodimerizations of olefins lined with a combination of hydrogen-bond-donor and -acceptor groups. Esters were used as protecting groups to generate head-to-head photodime

Design, synthesis, and biological evaluation of 17-cyclopropylmethyl-3, 14β-dihydroxy-4,5α-epoxy-6β-[(4′-pyridyl)carboxamido] morphinan derivatives as peripheral selective μ opioid receptor agents

Yuan, Yunyun,Elbegdorj, Orgil,Chen, Jianyang,Akubathini, Shashidhar K.,Zhang, Feng,Stevens, David L.,Beletskaya, Irina O.,Scoggins, Krista L.,Zhang, Zhenxian,Gerk, Phillip M.,Selley, Dana E.,Akbarali, Hamid I.,Dewey, William L.,Zhang, Yan

, p. 10118 - 10129 (2013/01/16)

Peripheral selective μ opioid receptor (MOR) antagonists could alleviate the symptoms of opioid-induced constipation (OIC) without compromising the analgesic effect of opioids. However, a variety of adverse effects were associated with them, partially due to their relatively low MOR selectivity. NAP, a 6β-N-4′-pyridyl substituted naltrexamine derivative, was identified previously as a potent and highly selective MOR antagonist mainly acting within the peripheral nervous system. The noticeable diarrhea associated with it prompted the design and synthesis of its analogues in order to study its structure-activity relationship. Among them, compound 8 showed improved pharmacological profiles compared to the original lead, acting mainly at peripheral while increasing the intestinal motility in morphine-pelleted mice (ED50 = 0.03 mg/kg). The slight decrease of the ED50 compared to the original lead was well compensated by the unobserved adverse effect. Hence, this compound seems to be a more promising lead to develop novel therapeutic agents toward OIC.

Development of tryptase inhibitors derived from thalidomide

Tetsuhashi, Masashi,Ishikawa, Minoru,Hashimoto, Mariko,Hashimoto, Yuichi,Aoyama, Hiroshi

experimental part, p. 5323 - 5338 (2010/09/15)

A novel series of tryptase inhibitors with a N-phenylphthalimide skeleton structurally derived from thalidomide (1) has been developed. Structure-activity relationship studies led to a potent and selective tryptase inhibitor, 2-(4-cyanophenyl)isoindole-1,3-dione-5-yl 3-(2-aminopyridin-5-yl)propanoate (7), with the IC50 value of 78 nM.

Efficient heterogeneous palladium-montmorillonite catalysts for heck coupling of aryl bromides and chlorides

Molnár, árpád,Papp, Attila

, p. 3130 - 3134 (2008/02/13)

New palladium catalysts were prepared using ion exchange or intercalation of Pd species into montmorillonite. The catalysts promote Heck reaction of various aromatic halides including aryl chlorides to give coupling products in high yields at low catalyst ratios down to 0.001 mol%. Georg Thieme Verlag Stuttgart.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 7340-34-3